Stage II results | ||
Number of patients | Number of remissions | |
38 | 38 (100 percent) | |
Low-risk | 22 | 22 (100 percent) |
Initial therapy | 17 (77.3 percent) | |
Sequential MTX/ActD | 16 | |
Combination chemotherapy* | 1 | |
Resistant therapy | 5 | 5 (22.7 percent) |
Combination chemotherapy* | 4 | |
Salvage therapy¶ | 1 | |
Stage III results | ||
Number of patients | Number of remissions | |
233 | 230 (98.7 percent) | |
Low-risk | 156 | 156 (100 percent) |
Initial therapy | 122 (78.2 percent) | |
Sequential MTX/ActD | 115 | |
Combination chemotherapyΔ | 7 | |
Resistant therapy | 34 | 34 (21.8 percent) |
Sequential MTX/ActD | 1 | |
Combination chemotherapyΔ | 33 |
Do you want to add Medilib to your home screen?